Key result
Prior stroke linked to ~2.5-fold higher risk of all-cause dementia, especially in APOE ε4 non-carriers.
Why the study?
Stroke and APOE ε4 are established dementia risk factors, but whether stroke interacts with APOE genotypes to influence dementia occurrence remains unclear.
Does a history of stroke interact with APOE genotypes to influence the incident risk of dementia in a population-based cohort?
Cohort (n=336,903)
Yes
Does a history of stroke interact with APOE genotypes to influence the incident risk of dementia in a population-based cohort?
Hazard Ratio: 2.52 (95% CI 2.26–2.81)
p-value: p=<0.001
A history of stroke significantly increases the risk of incident dementia, an effect that is paradoxically more pronounced in non-carriers of the APOE ε4 allele and potentially mediated by peripheral inflammatory pathways like TGF-beta signaling.
Stroke history may prompt genotype-informed dementia vigilance in non-carriers; leaves open mechanistic role of TGF-beta pathways.
Background Stroke and APOE ε4 are established risk factors of dementia. However, it remains unclear whether stroke interacts with APOE genotypes to influence dementia occurrence. This study aims to investigate the associations of stroke and its interaction by APOE genotypes with incident risk of dementia, with a specific focus on peripheral clues for biological mechanisms. Methods This prospective cohort study included 336 903 participants (mean age: 56.3 years, stroke history: 1.3%, APOE ε4: 28.5%) from the UK Biobank, with a median follow‐up of 13 years. Cumulative incidence curves were constructed using Fine–Gray death competing risks analysis. The additive and multiplicative interaction of stroke (including ischemic and hemorrhagic stroke) with APOE genotypes on incident risk of all‐cause dementia (ACD) and Alzheimer disease were examined. Blood proteomics combined with bioinformatics analyses were used to explore the peripheral clues for biological mechanisms. Results Either ischemic or hemorrhagic stroke was significantly associated with elevated risk of ACD and Alzheimer disease ( P <0.001). A significant multiplicative interaction was observed between stroke and APOE ε4 ( P <0.001). The association of stroke with increased risk of dementia was stronger in APOE ε4 non‐carriers than carriers, for both ACD (hazard ratio [HR], 1.93 for carriers and 3.36 for non‐carriers, P <0.001) and AD (HR, 1.14 for carriers and 2.67 for non‐carriers, P <0.001). Inflammation‐related pathways could be mechanisms underpinning the association of stroke with ACD risk. We identified 191 functionally interconnected ( P <1.0×10 −16 ) proteins associated with both stroke and ACD only in APOE ε4 non‐carriers. CD4‐related and TGF‐beta (transforming growth factor beta) signaling pathway could mediate the strengthened relationship in APOE ε4 non‐carriers. Conclusions Stroke interacts with APOE ε4 to influence dementia, with the association being more pronounced in APOE ε4 non‐carriers. Future studies are needed to verify the underpinning mechanisms to guide precise prevention.
No takes yet. Share an insight, caveat, or question.
Tan et al. (2025) conducted a cohort in Dementia (n=336,903). History of stroke vs. No history of stroke was evaluated on Incident all-cause dementia (ACD) (HR 2.52, 95% CI 2.26-2.81, p=<0.001). A history of stroke was significantly associated with a 2.52-fold increased risk of all-cause dementia, with the risk elevation being more pronounced in APOE ε4 non-carriers than in carriers.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: